206 related articles for article (PubMed ID: 4752049)
1. Cardiovascular and smooth muscle actions of some indolealkylamines.
Singh KP; Bhandari DS
Indian J Physiol Pharmacol; 1973; 17(1):31-9. PubMed ID: 4752049
[No Abstract] [Full Text] [Related]
2. Pharmacological studies of new indole alkaloids, rugulovasine A and B hydrochloride.
Nagaoka A; Kikuchi K; Nagawa Y
Arzneimittelforschung; 1972 Jan; 22(1):137-42. PubMed ID: 5066988
[No Abstract] [Full Text] [Related]
3. Some inhibitory actions of catecholamines and their blockade by propranolol.
Singh KP; Mahawar MM
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):58-67. PubMed ID: 5689546
[No Abstract] [Full Text] [Related]
4. [Pharmacological properties of some homologues of 5-methoxytryptamine].
Arutiunian GS
Farmakol Toksikol; 1967; 30(2):174-8. PubMed ID: 5628514
[No Abstract] [Full Text] [Related]
5. Cardiovascular effects of 2, 5-dimethoxy-4-methylamphetamine (DOM, STP).
Cheng HC; Long JP; Barfknecht CF; Nichols DE
J Pharmacol Exp Ther; 1973 Aug; 186(2):345-54. PubMed ID: 4719787
[No Abstract] [Full Text] [Related]
6. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
Levy B
J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047
[No Abstract] [Full Text] [Related]
7. Effect of imipramine on adrenergic responses.
Shaikh AA; Gulati OD; Parikh HM
Indian J Physiol Pharmacol; 1973; 17(4):299-309. PubMed ID: 4369955
[No Abstract] [Full Text] [Related]
8. [To the pharmacology of N-substituted 2,3-dihydroindoles].
Arnol'dova KA; Komissarov IV; Sheĭnkman AK
Farmakol Toksikol; 1966; 29(6):721-5. PubMed ID: 6000369
[No Abstract] [Full Text] [Related]
9. Pharmacological and behavioral effects of 3,4-dimethoxyphenylethylamine in conscious and anesthetized animals.
Brown ML; Lang WJ; Gershon S
Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):439-52. PubMed ID: 5868594
[No Abstract] [Full Text] [Related]
10. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle.
Besse JC; Bass AD
J Pharmacol Exp Ther; 1966 Nov; 154(2):224-38. PubMed ID: 5922985
[No Abstract] [Full Text] [Related]
11. [Pharmacological actions of "8204" on the cardiovascular system and bronchial smooth muscle].
Zhu ZH; Yang P; Tang ZN; Zeng YG; Dong J; Zheng LP; Wang ZT
Yao Xue Xue Bao; 1985 Dec; 20(12):886-90. PubMed ID: 3835800
[No Abstract] [Full Text] [Related]
12. [Pharmacologic characteristics of pyrroxan].
Krylov SS; Starykh NT
Farmakol Toksikol; 1973; 26(4):396-9. PubMed ID: 4151295
[No Abstract] [Full Text] [Related]
13. [Experimental pharmacology of ginkgo-biloba].
Herz W
Minerva Med; 1973 Nov; 64(79 Suppl):4160-6. PubMed ID: 4798569
[No Abstract] [Full Text] [Related]
14. Some pharmacological actions of acenocoumarin.
Jindal MN; Shah DS
Arzneimittelforschung; 1966 Jul; 16(7):878-81. PubMed ID: 6014718
[No Abstract] [Full Text] [Related]
15. Analysis of the effects of some new derivatives of ethylenediamine on the cardiovascular system. Studies on general pharmacological properties.
Filczewski M
Acta Physiol Pol; 1974; 25(6):565-76. PubMed ID: 4456970
[No Abstract] [Full Text] [Related]
16. [General pharmacological studies with HB 419].
Pfaff W; Bänder A; Starey F; Hardebeck K; Ritter K; Wohlfarth A
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1378-81. PubMed ID: 4390511
[No Abstract] [Full Text] [Related]
17. Studies relating to the antihypertensive and antidysrhythmic action of indoramin.
Baum T; Shropshire AT; Eckfeld DK; Metz N; Dinish JL; Peters JR; Butz F; Gluckman MI
Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):390-406. PubMed ID: 4356047
[No Abstract] [Full Text] [Related]
18. [The pharmacologic basis of the antidepressive activity of the new psychotropic preparation pyrazidol].
Mashkovskiĭ MD; Andreeva NI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(3):430-5. PubMed ID: 1078927
[No Abstract] [Full Text] [Related]
19. Autonomic blocking properties of Wy 21901.
Alps BJ; Hill M; Johnson ES; Wilson AB
Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084
[No Abstract] [Full Text] [Related]
20. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
